Where does Sophie Allauzen work?

Sophie Allauzen is Senior Advisor at Adjuvant Capital.

What does Sophie Allauzen invest in?

Sophie Allauzen invests in Biotech, Digital Health, Medical Devices.

Where did Sophie Allauzen go to school?

Sophie Allauzen studied at Harvard Business School Executive Education (Business Administration and Management, General); UC San Diego; University of Colorado Boulder (BA).

Sophie Allauzen

Investor

Senior Advisor at Adjuvant Capital · Venture Partner at Acequia Capital (AceCap)

San Francisco, CA

About

Sophie Allauzen has two decades of international experience in R&D, business development, and portfolio management across diagnostic industries, covering the full lifecycle of diagnostic products in both developed and developing markets. Her background includes overseeing malaria and neglected-disease diagnostic programs at the Bill & Melinda Gates Foundation, leading blood testing at Novartis Diagnostics, and managing R&D for immuno-assays at Bio-Rad, following five years in infectious disease test development at Sanofi Diagnostics Pasteur in France. She holds a PhD in biochemistry/immunology from Montpellier University and completed a postdoctoral fellowship in allergy at the University of Minnesota; she currently works as an independent consultant.

Invests in

BiotechDigital HealthMedical Devices

Experience

Acequia CapitalVenture Partnercurrent2023 — present
North America CloseshoringChief Executive Officercurrent2020 — present
The Broe GroupSenior Vice President Business Development2019 — 2020
OmniTRAX, Inc.VP Development Affairs2014 — 2019An affiliated company of The Broe Group
The Broe GroupVP2011 — 2014
Simon l SemenoffCo-Founder/Partner2007 — 2011
FOGNANI & ASSOCIATES PLLCPartner2004 — 2007
Dorsey & Whitney LLPPartner2002 — 2004
Greenberg TraurigPartner1999 — 2002

Skills & more

IT StrategyInvestmentsReindustrializationStart-ups20Venture Capital14Entrepreneurship12Mergers & Acquisitions9Strategic Partnerships9Business Planning8Business Strategy6Social Media7Strategic Planning6

+12 more

Project ManagementSoftware DevelopmentNew Business DevelopmentMergersReal Estate DevelopmentRailroad ExecutivePrivate EquityStrategyE-commerceExecutive ManagementBusiness DevelopmentMarketing Strategy

From Sophie's professional profile.

Colleagues at Adjuvant Capital

Abrar Haque

Associate at Adjuvant Capital

Alexandra (Sandra) Glucksmann

Advisory Partner at Adjuvant Capital

Christian Mandl

Senior Advisor at Adjuvant Capital

Curt LaBelle

Venture Partner at Adjuvant Capital

Evelyn Yanatos

Director of Finance and Compliance at Adjuvant Capital

Gerard Cunningham

Operating Partner at Adjuvant Capital

Giulia Balconi

Associate at Adjuvant Capital

Glenn Rockman

Co-Founder and Partner at Adjuvant Capital

Frequently asked questions

Who is Sophie Allauzen?: Sophie Allauzen has two decades of international experience in R&D, business development, and portfolio management across diagnostic industries, covering the full lifecycle of diagnostic products in both developed and developing markets. Her background includes overseeing malaria and neglected-disease diagnostic programs at the Bill & Melinda Gates Foundation, leading blood testing at Novartis Diagnostics, and managing R&D for immuno-assays at Bio-Rad, following five years in infectious disease test development at Sanofi Diagnostics Pasteur in France. She holds a PhD in biochemistry/immunology from Montpellier University and completed a postdoctoral fellowship in allergy at the University of Minnesota; she currently works as an independent consultant.
Where does Sophie Allauzen work?: Sophie Allauzen is Senior Advisor at Adjuvant Capital.
What does Sophie Allauzen invest in?: Sophie Allauzen invests in Biotech, Digital Health, Medical Devices.
Where did Sophie Allauzen go to school?: Sophie Allauzen studied at Harvard Business School Executive Education (Business Administration and Management, General); UC San Diego; University of Colorado Boulder (BA).

Same school

Also attended Harvard Business School Executive Education170

Konstantin DzhengozovCo-founder & CFO of Payhawk Chris FeeneySenior Fellow, Bank Policy Institute at MissionOG Alina GouninaInvestor at Moonfire Ventures Ryan LaurinManaging Director at Marlin Equity Partners Paul SlosarInvestor at FortySix Venture Capital Raghu MadabushiInvestment Director at Samsung Catalyst Fund

+ 164 more

Also attended UC San Diego329

Elad GilSolo general partner investing through Gil Capital Mark SusterManaging Partner at Upfront Ventures Chester NgGeneral Partner at Atomic BirgitteInvestor at Investinor Houman HaghighiPartner, Business & Corporate Development at Menlo Ventures Freya Svedberg-KeatingInvestor at Medicxi

+ 323 more

Also attended University of Colorado Boulder237

Steve WozniakCo-founder of Apple Chris RustCo-Founder and Partner at Clear Ventures Sydney EberhardtInvestor at True Ventures Bob ThomasPartner at Oxx Kirsten SuddathInvestor at Next Frontier Capital Stephanie CarrollAssistant Fund Controller at JMI Equity

+ 231 more

Also attended University of Denver - Sturm College of Law2

Bob LembkeAdvisor at ICI Dominic LloydManaging Director at Link Ventures

Shared employers

Also worked at Dorsey & Whitney LLP8

Laura RaffertyUniversity Venture Fellow (Summer 2025) at Rebalance Capital Ventures Michael McFallGC at Two Magnolias Tony WiseAdvisor at Capriole Investments Kristen McVeetyGeneral Counsel at CoreWeave Laura RaffertyInvestor at Coyote Ventures Danny BriskinOperating Partner, Human Resources at Greybull Stewardship LLC

+ 2 more

Also worked at Greenberg Traurig7

Camille MansoBusiness Development at KPCB Mark PlandowskiGeneral Counsel at Agman Partners Estefanía MenesesSenior Associate – Legal at Discovery Americas Ashley FlucasFounder at Flucas Ventures Glenn BiermanManaging Partner at Tycon Partners Joshua B. GordonVice President of Health Care – Medicare Sustainability & Provider Payment Incentives at Arnold Ventures

+ 1 more